Tempest Therapeutics Inc. (TPST) Live Share Price, Invest From India

Tempest Therapeutics Inc. Stock Performance

as on June 19, 2026 at 2:15 pm IST

Day's Low
Day's High
$1.22
Day's Price Range
$1.26
$1.23
0.81%
Downside
2.44%
Upside
52 Week's Low
52 Week's High
$1.20
52-Week Price Range
$6.12
$1.23
2.44%
Downside
397.15%
Upside

Tempest Therapeutics Inc. share price movements today

Previous Close: $1.25
Open: $1.25
Volume: 334.3K
Day's Low - High: $1.22 - $1.26
52 Week Low - High: $1.20 - $6.12

Tempest Therapeutics Inc. Historical Returns

1 Month Return: -30.9 %
3 Month Return: -43.06 %
1 Year Return: -64.35 %
3 Year Return: -85.98 %
5 Year Return: 0 %

Tempest Therapeutics Inc. Stock Fundamentals & Key Indicators

Check Tempest Therapeutics Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$18.5M

EPS (TTM)

-1.34

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

PEG Ratio

EBITDA

-20.9M

Revenue (TTM)

Profit Margin

0.00%

Return On Equity TTM

-721.00%

Tempest Therapeutics Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Tempest Therapeutics Inc. with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %	Dividend Yield %
Tempest Therapeutics Inc.	BUY	$18.5M	NA	NA	0.00%	NA
Alnylam Pharmaceuticals Inc.	BUY	$37.7B	57.21%	71.21	12.55%	NA
Vertex Pharmaceuticals Inc.	BUY	$116.5B	140.42%	27.22	35.51%	NA
Regeneron Pharmaceuticals Inc.	BUY	$63.7B	13.39%	14.85	29.65%	0.58%

Stock Returns calculator for Tempest Therapeutics Inc. Stock including INR - Dollar returns

The Tempest Therapeutics Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

Tempest Therapeutics Inc. investment value today

Current value as on today

₹38,835

Returns

-₹61,165

(-61.16%)

Returns from Tempest Therapeutics Inc. Stock

-₹64,348 (-64.35%)

Dollar Impact

₹3,183 (+3.18%)

Analyst Recommendation on Tempest Therapeutics Inc. Stock

Based on 12 analysts

BUY

91.67%

Buy

8.33%

Hold

0.00%

Sell

Based on 12 analysts, 91.67% of analysts recommend a 'BUY' rating for Tempest Therapeutics Inc.. Average target price of $11

Tempest Therapeutics Inc. Share Price Target

Get share price movements and forecasts by analysts on Tempest Therapeutics Inc..

What analysts predicted

88.82%UPSIDE

Target Price

$11

Current Price

$1.23

Analyzed by

12 Analysts

Target

$11.00

Tempest Therapeutics Inc. target price $11, a slight upside of 88.82% compared to current price of $1.23. According to 12 analysts rating.

Indian Investors' Interest in Tempest Therapeutics Inc. Stock

Search interest for Tempest Therapeutics Inc. Stock has decreased by -20% in the last 30 days, reflecting a downward trend in search activity.

Time period: May 21, 2026 to June 20, 2026

Change:-20% versus previous 30 day period

Tempest Therapeutics Inc. Quarterly Profit & Loss

All numbers in Millions USD

	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Total Revenue	-	-	-	-	0	0	-	-	-	-
Gross Profit	0	0	0	0	0	0	0	0	0	-22
Operating Income	-7	-7	-9	-10	-13	-10	-7	-3	-4	-27
EBITDA	-7	-7	-9	-10	-13	-10	-7	-3	-3	-27
Interest Expense	0	0	0	0	0	0	0	0	0	0
Depreciation	0	0	0	0	0	0	0	0	0	0
Income Before Tax	-7	-7	-9	-10	-13	-10	-7	-3	-4	-27
Income Tax Expense	0	0	-	-	0	-	-	-	-	-
Net Income	-7	-7	-9	-10	-13	-10	-7	-3	-4	-27
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	-2842.18%	-2234.57%	0.00%	0.00%	0.00%	0.00%

Tempest Therapeutics Inc. Annual Profit & Loss

All numbers in Millions USD

	Dec 2016	Dec 2017	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Revenue	0	0	-	-	-	-	-	-
Gross Profit	-4	0	0	-1	-1	0	0	-
Operating Income	-81	-20	-19	-26	-34	-29	-42	-26
EBITDA	-79	-84	-18	-26	-33	-27	-40	-25
Interest Expense	0	-	0	1	1	1	1	0
Depreciation	-	-	0	0	0	0	0	0
Income Before Tax	-82	-84	-19	-28	-35	-29	-41	-26
Income Tax Expense	0	0	0	1	1	-	-41	-
Net Income	-82	-84	-19	-28	-35	-29	-41	-26
Net Profit Margin	-12597.24%	-28670.51%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Tempest Therapeutics Inc. Quarterly Cash Flow

All numbers in Millions USD

	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Net Income	-7	-9	-10	-13	-10	-7	-3	-4	-27
Operating Cash Flow	-7	-5	-10	-10	-8	-8	-6	-3	-7
Investing Cash Flow	0	0	0	0	-	-	-	-	-
Financing Cash Flow	0	4	1	17	0	1	0	3	1
Change in Cash	-6	-1	-8	7	-8	-7	-6	0	-5

Tempest Therapeutics Inc. Annual Cash Flow

All numbers in Millions USD

	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Net Income	-84	-27	-44	-19	-28	-35	-29	-41	-26
Operating Cash Flow	-20	-23	-41	-19	-25	-31	-27	-33	-26
Investing Cash Flow	0	1	3	0	0	0	0	0	-
Financing Cash Flow	-4	78	26	34	59	11	35	24	4
Change in Cash	-26	55	-9	15	33	-20	8	-8	-22

Global Institutional Holdings in Tempest Therapeutics Inc.

Funds	Holdings
SBI Securities Co Ltd	0%
Global Retirement Partners, LLC.	0%
Royal Bank of Canada	0%
Vanguard Group Inc	1.1%
Millennium Management LLC	0%

See all

Insights on Tempest Therapeutics Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

NO EFFECT
Against Peers
In the last 3 years, Tempest Therapeutics, Inc. Common Stock has experienced a drawdown of -85.2%, however Alnylam Pharmaceuticals, Inc. Common Stock resisted the overall trend and outperformed by 63.3%
NO EFFECT
Against Peers
In the last 1 year, Regeneron Pharmaceuticals, Inc. Common Stock has given 19.7% return, outperforming this stock by 83.4%
NEGATIVE IMPACT
Price Dip
In the last 1 month, TPST stock has moved down by -33.9%

About Tempest Therapeutics Inc.

Tempest Therapeutics, Inc., a clinical-stage biotechnology company, develops small molecule therapeutics to treat cancer. Its lead product candidates include Amezalpat, an oral small molecule selective antagonist of peroxisome proliferator-activated receptor alpha for the treatment of first-line unresectable or metastatic hepatocellular carcinoma that completed Phase 2 clinical trial; and TPST-1495, a small-molecule dual antagonist of the EP2 and EP4 receptors of prostaglandin E2 for treating various cancers. The company has a collaboration agreement with F. Hoffmann-La Roche Ltd. for the development of Amezalpat into a global first-line randomized study. Tempest Therapeutics, Inc. is headquartered in Brisbane, California.

Organisation	Tempest Therapeutics Inc.
Headquarters	2000 Sierra Point Parkway, Brisbane, CA, United States, 94005
Industry	Biotechnology
CEO	Dr. Matthew Angel Ph.D.
E-voting on shares	Click here to vote

Key Management of Tempest Therapeutics Inc.

Name	Title
Mr. Justin Trojanowski CPA	VP of Finance, Corp. Controller, Treasurer, Secretary and Principal Financial & Accounting Officer
Dr. Andrew Fang Ph.D.	Head of Business Development
Dr. Matthew Angel Ph.D.	President, CEO & Director

FAQs

What is Tempest Therapeutics Inc. share price today?

Tempest Therapeutics Inc. share price today is $1.23 as on June 19, 2026 at 8:45 am IST at the close of the market. Tempest Therapeutics Inc. share today touched a day high of $1.26 and a low of $1.22.

What is the 52 week high and 52 week low for Tempest Therapeutics Inc. share?

Tempest Therapeutics Inc. share touched a 52 week high of $6.12 on October 15, 2025 and a 52 week low of $1.2 on January 15, 2026. Tempest Therapeutics Inc. stock price today i.e. June 19, 2026 at 8:45 am IST is closed at $1.23,which is 79.89% down from its 52 week high and 2.50% up from its 52 week low.

What is Tempest Therapeutics Inc.'s market capitalisation today?

Tempest Therapeutics Inc. market capitalisation is $0.00T as on June 19, 2026 at 8:45 am IST.

How to invest in Tempest Therapeutics Inc. Stock (TPST) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Tempest Therapeutics Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Tempest Therapeutics Inc. Shares that will get you 1.2195 shares as per Tempest Therapeutics Inc. share price of $1.23 per share as on June 19, 2026 at 8:45 am IST.

What is the minimum amount required to buy Tempest Therapeutics Inc. Stock (TPST) from India?

Indian investors can start investing in Tempest Therapeutics Inc. (TPST) shares with as little as ₹94.31 or $1 (as of June 20, 2026 at 9:01 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹943.10 in Tempest Therapeutics Inc. stock (as per the Rupee-Dollar exchange rate as on June 20, 2026 at 9:01 pm IST). Based on Tempest Therapeutics Inc. share’s latest price of $1.23 as on June 19, 2026 at 8:45 am IST, you will get 8.1301 shares of Tempest Therapeutics Inc.. Learn more about fractional shares .